Study to Investigate the Safety of LT5001 Drug Product for Uremic Pruritus in Hemodialysis Patients
Clinical trial NCT04393675 · TERMINATED
Trial details
- NCT number
- NCT04393675
- Sponsor
- Lumosa Therapeutics Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-14
- Primary completion
- 2022-09-15
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.